Pharmaceutical Business review

Warburg Pincus completes acquisition of Bausch & Lomb

Ronald Zarrella, chairman and CEO of Bausch & Lomb, said: “With a strong and supportive partner in Warburg Pincus, we are well-positioned to create new opportunities for Bausch & Lomb and advance our leadership in the eye health industry. Our customers will continue to receive high levels of service, product quality and innovation, and our commitment to serving their needs remains steadfast. On behalf of Bausch & Lomb’s management and board of directors, I want to thank our shareholders and hard-working employees for their support throughout this process.”

Elizabeth Weatherman, a Warburg Pincus managing director, said: “We are delighted to be partners with Bausch & Lomb, a global leader in vision care, ophthalmic devices and pharmaceuticals. We look forward to helping the company build upon its rich heritage and premier brand in ophthalmology.”